Shilpa Medicare Limited — Important, 23-05-2025: General Updates

Shilpa Biocare, Shilpa Medicare’s subsidiary, has partnered with Finland’s Orion Corporation to commercialize Recombinant Human Albumin in Europe. Orion will handle distribution and sales exclusively, while Shilpa earns development and regulatory milestone payments. The product offers a safer, virus-free alternative to human-derived albumin, important for therapeutics and biologics manufacturing. This alliance boosts Shilpa’s global biotech presence by leveraging Orion’s established network in Europe.